Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma

Progestin resistance is a problem for patients with endometrial carcinoma (EC) who require conservative treatment with progestin, and its underlying mechanisms remain unclear. YAP and TAZ (YAP/TAZ), downstream transcription coactivators of Hippo pathway, promote viability, metastasis and also drug r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Lina, Ma, Xiaohong, Hou, Yixin, Zhao, Tianyi, Sun, Rui, Qiu, Chunping, Liu, Yao, Qiu, Ziyi, Liu, Zhiming, Jiang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873621/
https://www.ncbi.nlm.nih.gov/pubmed/36693834
http://dx.doi.org/10.1038/s41420-023-01319-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873621/
https://www.ncbi.nlm.nih.gov/pubmed/36693834
http://dx.doi.org/10.1038/s41420-023-01319-y

Ejemplares similares